Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Cardiovascular risk and hippocampal-cognitive coupling in Alzheimer’s disease

View through CrossRef
Abstract INTRODUCTION The Framingham Risk Score (FRS) indexes cardiovascular risk (CVR), but age-weighting may confound associations with brain and cognitive outcomes. METHODS In 923 amyloid-positive ADNI participants, we compared FRS against a Multiple Indicators Multiple Causes (MIMIC)-derived age-adjusted measure (CVR mimic ) using sex-stratified linear mixed-effects (LME) and latent growth curve mediation (LGCM) models of hippocampal-to-ventricle ratio (HVR)– cognitive coupling. RESULTS FRS predicted hippocampal atrophy in all six LGCM models; CVR mimic in none of the six. HVR–cognitive coupling held in four of six FRS and four of six CVR mimic models. Indirect effects reached significance in four of six FRS and none of the six CVR mimic models. LME 3-way interactions (years × risk × HVR) survived FDR correction in all six FRS versus none of the six CVR mimic models. DISCUSSION FRS “effects” on hippocampal-cognitive decline largely reflect age-related variance. Age-adjusted measures complement FRS by isolating cardiovascular effects from aging. Research in Context Systematic Review The Framingham Risk Score (FRS) predicts brain atrophy and cognitive decline across cohorts [1–4]. Yet age dominates the FRS [5,6] and accounts for most of its predictive value in older adults [7,8], suggesting these associations may reflect age confounding. No prior study has compared FRS against an age-adjusted latent measure. Interpretation FRS indirect effects on cognitive decline via hippocampal atrophy primarily reflect age-weighting; age is itself a legitimate vascular proxy [9]. Partialling out age (CVR mimic ) nullified the cardiovascular-risk-to-hippocampal pathway, while HVR-cognitive coupling persisted, indicating coupling reflects neurodegeneration. Prior FRS-brain reports likely conflate age-driven and cardiovascular effects. Future Directions Replication in independent aging cohorts with longitudinal cardiovascular measurement is needed. The MIMIC age-adjustment framework can be applied to any composite risk score where age confounding is a concern. Intervention trials should test whether cardiovascular management preserves hippocampal-cognitive coupling using age-adjusted endpoints rather than FRS. Highlights Age-adjusted cardiovascular risk does not accelerate hippocampal atrophy Hippocampal-cognitive coupling persists regardless of how risk is measured FRS-brain associations in elderly samples primarily reflect age-weighting A reverse pattern in amyloid-negative controls supports a cognitive reserve effect MIMIC-based age-adjustment generalizes to any age-confounded composite score
Title: Cardiovascular risk and hippocampal-cognitive coupling in Alzheimer’s disease
Description:
Abstract INTRODUCTION The Framingham Risk Score (FRS) indexes cardiovascular risk (CVR), but age-weighting may confound associations with brain and cognitive outcomes.
METHODS In 923 amyloid-positive ADNI participants, we compared FRS against a Multiple Indicators Multiple Causes (MIMIC)-derived age-adjusted measure (CVR mimic ) using sex-stratified linear mixed-effects (LME) and latent growth curve mediation (LGCM) models of hippocampal-to-ventricle ratio (HVR)– cognitive coupling.
RESULTS FRS predicted hippocampal atrophy in all six LGCM models; CVR mimic in none of the six.
HVR–cognitive coupling held in four of six FRS and four of six CVR mimic models.
Indirect effects reached significance in four of six FRS and none of the six CVR mimic models.
LME 3-way interactions (years × risk × HVR) survived FDR correction in all six FRS versus none of the six CVR mimic models.
DISCUSSION FRS “effects” on hippocampal-cognitive decline largely reflect age-related variance.
Age-adjusted measures complement FRS by isolating cardiovascular effects from aging.
Research in Context Systematic Review The Framingham Risk Score (FRS) predicts brain atrophy and cognitive decline across cohorts [1–4].
Yet age dominates the FRS [5,6] and accounts for most of its predictive value in older adults [7,8], suggesting these associations may reflect age confounding.
No prior study has compared FRS against an age-adjusted latent measure.
Interpretation FRS indirect effects on cognitive decline via hippocampal atrophy primarily reflect age-weighting; age is itself a legitimate vascular proxy [9].
Partialling out age (CVR mimic ) nullified the cardiovascular-risk-to-hippocampal pathway, while HVR-cognitive coupling persisted, indicating coupling reflects neurodegeneration.
Prior FRS-brain reports likely conflate age-driven and cardiovascular effects.
Future Directions Replication in independent aging cohorts with longitudinal cardiovascular measurement is needed.
The MIMIC age-adjustment framework can be applied to any composite risk score where age confounding is a concern.
Intervention trials should test whether cardiovascular management preserves hippocampal-cognitive coupling using age-adjusted endpoints rather than FRS.
Highlights Age-adjusted cardiovascular risk does not accelerate hippocampal atrophy Hippocampal-cognitive coupling persists regardless of how risk is measured FRS-brain associations in elderly samples primarily reflect age-weighting A reverse pattern in amyloid-negative controls supports a cognitive reserve effect MIMIC-based age-adjustment generalizes to any age-confounded composite score.

Related Results

Penerapan Metode Convolutional Neural Network untuk Diagnosa Penyakit Alzheimer
Penerapan Metode Convolutional Neural Network untuk Diagnosa Penyakit Alzheimer
Abstract— Alzheimer's disease is a neurodegenerative disease that develops gradually, and is associated with cardiovascular and cerebrovascular problems. Alzheimer's is a serious d...
MRI Assessment of Brain Volume Changes in Alzhiemer’s Disease and Their Relationship with Cognitive Decline
MRI Assessment of Brain Volume Changes in Alzhiemer’s Disease and Their Relationship with Cognitive Decline
Background: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by memory loss, cognitive decline and behavioral changes. Structural brain changes, p...
Race, polygenic risk and their association with incident dementia among older US adults
Race, polygenic risk and their association with incident dementia among older US adults
AbstractDementia incidence increases steadily with age at rates that may vary across racial groups. This racial disparity may be attributable to polygenic risk, as well as lifestyl...
Hippocampal Volume Loss as A Marker of Cognitive Decline in Dementia and Mild Cognitive Impairment: A Comprehensive Prospective Study
Hippocampal Volume Loss as A Marker of Cognitive Decline in Dementia and Mild Cognitive Impairment: A Comprehensive Prospective Study
Background: Hippocampal atrophy is a hallmark of cognitive decline observed in dementia and mild cognitive impairment (MCI). This study investigated hippocampal volumes across indi...
Clinical characteristics and biomarker profile in early- and late-onset Alzheimer’s disease: the Shanghai Memory Study
Clinical characteristics and biomarker profile in early- and late-onset Alzheimer’s disease: the Shanghai Memory Study
Abstract Early-onset Alzheimer’s disease constitutes ∼5–10% of Alzheimer’s disease. Its clinical characteristics and biomarker profiles are not well documented. To c...
Cardiovascular Risk and Hippocampal Thickness in Alzheimer’s Disease
Cardiovascular Risk and Hippocampal Thickness in Alzheimer’s Disease
Cardiovascular risk factors influence onset and progression of Alzheimer’s disease. Among cognitively healthy people, changes in brain structure and function associated with high b...
Nonlinear biomarker interactions in conversion from Mild Cognitive Impairment to Alzheimer’s disease
Nonlinear biomarker interactions in conversion from Mild Cognitive Impairment to Alzheimer’s disease
Abstract The multi-faceted nature of Alzheimer’s disease means that multiple biomarkers (e.g., amyloid-β, tau, brain atrophy) can contribute to t...

Back to Top